No Tax Breaks for Drug Ads Act

Bill: 117-hr-6392
Sponsor: full_name: Rep. Slotkin, Elissa [D-MI-8]
Introduced: 2022-01-13
Policy area: Taxation
Latest action: action_date: 2022-01-13
text: Referred to the House Committee on Ways and Means.

Summaries:
action_date: 2022-01-13
action_desc: Introduced in House
text: <p><strong>No Tax Breaks for Drug Ads Act</strong></p> <p>This bill prohibits a tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs. </p> <p><i>Direct-to-consumer advertising</i> is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is in regard to the drug product and primarily targeted to the general public.</p>

tv_txt: I 117th CONGRESS 2d Session H. R. 6392 IN THE HOUSE OF REPRESENTATIVES January 13, 2022 Ms. Slotkin (for herself and Mr. Trone ) introduced the following bill; which was referred to the Committee on Ways and Means A BILL To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.

1. Short title This Act may be cited as the No Tax Breaks for Drug Ads Act . 2. Disallowance of deduction for advertising and promotional expenses for prescription drugs (a) In general Part IX of subchapter B of chapter 1 of subtitle A of the Internal Revenue Code of 1986 (relating to items not deductible) is amended by adding at the end the following new section: 280I. Disallowance of deduction for direct-to-consumer advertising of prescription drugs (a) In general No deduction shall be allowed under this chapter for expenses relating to direct-to-consumer advertising of prescription drugs for any taxable year. (b) Direct-to-Consumer advertising For purposes of this section, the term direct-to-consumer advertising means any dissemination, by or on behalf of a sponsor of a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), of an advertisement which— (1) is in regard to such prescription drug product, and (2) primarily targeted to the general public, including through— (A) publication in journals, magazines, other periodicals, and newspapers, (B) broadcasting through media such as radio, television, and telephone communication systems, direct mail, and billboards, and (C) dissemination on the Internet or through digital platforms (including social media, mobile media, web applications, digital applications, mobile applications, and electronic applications). . (b) Conforming amendment The table of sections for such part IX of the Internal Revenue Code of 1986 is amended by adding after the item relating to section 280H the following new item: Sec. 280I. Disallowance of deduction for direct-to-consumer advertising of prescription drugs. . (c) Effective date The amendments made by this section shall apply to amounts paid or incurred after the date of the enactment of this Act, in taxable years ending after such date.